{"id":52195,"name":"UROGEN PHARMA, INC.","slug":"urogen-pharma-inc","state":"NJ","country":"United States of America","description":"Biopharmaceutical company","totalSpending":470000,"filings":16,"yearlySpending":[{"year":2022,"income":140000},{"year":2023,"income":120000},{"year":2024,"income":90000},{"year":2025,"income":120000}],"issues":[{"code":"HCR","display":"Health Issues"}],"firms":["BGR GOVERNMENT AFFAIRS"],"lobbyists":["ROBB WALTON","ROBERT WOOD","DANIEL FARMER","REMY MASON"],"govEntities":["HOUSE OF REPRESENTATIVES","SENATE","Centers For Medicare and Medicaid Services (CMS)"],"sampleDescriptions":["Provide strategic counsel and advocacy for issues related to cancer and urologic disease treatments and regulatory reimbursement policy around requirement for manufacturers to provide refunds to Medic","Provide strategic counsel and advocacy for issues related to cancer and urologic disease treatments and regulatory reimbursement policy around requirement for manufacturers to provide refunds to Medic","Provide strategic counsel and advocacy for issues related to cancer and urologic disease treatments and regulatory reimbursement policy around requirement for manufacturers to provide refunds to Medic","Provide strategic counsel and advocacy for issues related to cancer and urologic disease treatments and regulatory reimbursement policy around requirement for manufacturers to provide refunds to Medic","Provide strategic counsel and advocacy for issues related to cancer and urologic disease treatments and regulatory reimbursement policy around requirement for manufacturers to provide refunds to Medic"]}